{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:42:43Z","timestamp":1794465763870,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The triglyceride and glucose index (TyG), as a surrogate of insulin resistance (IR), is closely associated with non-alcoholic fatty liver disease (NAFLD). However, the association between the TyG index and NAFLD in atrial fibrillation (AF) is unknown. Therefore, the purpose of this study is to explore the association between the TyG index and NAFLD in AF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study was performed at Nanchang University\u2019s Second Affiliated Hospital. The AF patients who were hospitalized from January 2021 to December 2022 were enrolled. The association between the TyG index and NAFLD in AF patients was assessed by logistic regression and restricted cubic spline analysis. The ability of TyG index for identifying NAFLD was estimated by the area under the receiver operating characteristic (ROC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, 632 people participated in the final analysis, with 176 (27.84%) having NAFLD. In the full adjustment model, there is an association between the TyG index and NAFLD [per 1 unit increment; odds ratios (ORs): 3.28; 95% confidence interval (CI) 2.14, 5.03]. Compared to the lowest tertile (TyG index &lt;\u20098.29), the ORs for the highest tertile (TyG index \u2265\u20098.82) were 4.15 (95%CI: 2.28, 7.53). Dose\u2013response analysis showed that the TyG index and NAFLD have a nearly linear relationship (<jats:italic>P<\/jats:italic> non-linear\u2009=\u20090.71). The area under the curve (AUC) of the TyG index is 0.735.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings showed a significant association between the TyG index and NAFLD. The TyG index may be a good marker for predicting NAFLD in AF patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01188-2","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T05:02:13Z","timestamp":1695099733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association between the Triglyceride\u2013Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation"],"prefix":"10.1186","volume":"28","author":[{"given":"Xiaozhong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0508-8470","authenticated-orcid":false,"given":"Juxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"issue":"10290","key":"1188_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324. https:\/\/doi.org\/10.1016\/s0140-6736(20)32511-3.","journal-title":"Lancet"},{"issue":"1","key":"1188_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1188_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"4","key":"1188_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","volume":"70","author":"F Zhou","year":"2019","unstructured":"Zhou F, Zhou J, Wang W, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70(4):1119\u201333. https:\/\/doi.org\/10.1002\/hep.30702.","journal-title":"Hepatology"},{"issue":"11","key":"1188_CR5","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/hep4.1419","volume":"3","author":"JM Paik","year":"2019","unstructured":"Paik JM, Henry L, De Avila L, Younossi E, Racila A, Younossi ZM. Mortality related to nonalcoholic fatty liver disease is increasing in the United States. Hepatol Commun. 2019;3(11):1459\u201371. https:\/\/doi.org\/10.1002\/hep4.1419.","journal-title":"Hepatol Commun"},{"issue":"7","key":"1188_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","volume":"15","author":"QM Anstee","year":"2018","unstructured":"Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15(7):425\u201339. https:\/\/doi.org\/10.1038\/s41575-018-0010-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1188_CR7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/liv.14044","volume":"39","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dauriz M, Sandri D, et al. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis. Liver Int. 2019;39(4):758\u201369. https:\/\/doi.org\/10.1111\/liv.14044.","journal-title":"Liver Int"},{"key":"1188_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/10815589231164777","author":"V Jaiswal","year":"2023","unstructured":"Jaiswal V, Ang SP, Huang H, et al. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis. J Investig Med. 2023. https:\/\/doi.org\/10.1177\/10815589231164777.","journal-title":"J Investig Med"},{"issue":"10","key":"1188_CR9","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/cir.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56\u2013528. https:\/\/doi.org\/10.1161\/cir.0000000000000659.","journal-title":"Circulation"},{"issue":"7","key":"1188_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110(7):921\u201337. https:\/\/doi.org\/10.1007\/s00392-020-01709-7.","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"1188_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/10641963.2016.1267193","volume":"39","author":"X Sun","year":"2017","unstructured":"Sun X, Chen Y, Zeng Q, Huang X, Cai J. Reduction of leukocyte-derived H(2)S linked to abnormal glycolipid metabolism in hypertensive subjects. Clin Exp Hypertens. 2017;39(5):427\u201334. https:\/\/doi.org\/10.1080\/10641963.2016.1267193.","journal-title":"Clin Exp Hypertens"},{"key":"1188_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113863","author":"H Fujii","year":"2020","unstructured":"Fujii H, Kawada N, Japan Study Group Of Nafld Jsg-Nafld. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21113863.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1188_CR13","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","volume":"93","author":"AC Vasques","year":"2011","unstructured":"Vasques AC, Novaes FS, de Oliveira MS, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98\u2013100. https:\/\/doi.org\/10.1016\/j.diabres.2011.05.030.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1188_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","volume":"16","author":"S Zhang","year":"2017","unstructured":"Zhang S, Du T, Zhang J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15. https:\/\/doi.org\/10.1186\/s12944-017-0409-6.","journal-title":"Lipids Health Dis"},{"key":"1188_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092251","author":"S Song","year":"2022","unstructured":"Song S, Son DH, Baik SJ, Cho WJ, Lee YJ. Triglyceride glucose\u2013waist circumference (TyG\u2013WC) is a reliable marker to predict non-alcoholic fatty liver disease. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10092251.","journal-title":"Biomedicines"},{"key":"1188_CR16","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2147\/ijgm.S350474","volume":"15","author":"L Hu","year":"2022","unstructured":"Hu L, Bao H, Huang X, et al. Relationship between the triglyceride glucose index and the risk of first stroke in elderly hypertensive patients. Int J Gen Med. 2022;15:1271\u20139. https:\/\/doi.org\/10.2147\/ijgm.S350474.","journal-title":"Int J Gen Med"},{"issue":"14","key":"1188_CR17","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.7150\/ijms.62010","volume":"18","author":"C Wang","year":"2021","unstructured":"Wang C, Cai Z, Deng X, et al. Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes. Int J Med Sci. 2021;18(14):3280\u20139. https:\/\/doi.org\/10.7150\/ijms.62010.","journal-title":"Int J Med Sci"},{"issue":"4","key":"1188_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jama.2021.23732","volume":"327","author":"KW Davidson","year":"2022","unstructured":"Davidson KW, Barry MJ, Mangione CM, et al. Screening for atrial fibrillation: US Preventive Services Task Force Recommendation Statement. JAMA. 2022;327(4):360\u20137. https:\/\/doi.org\/10.1001\/jama.2021.23732.","journal-title":"JAMA"},{"issue":"1","key":"1188_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22(1):63. https:\/\/doi.org\/10.1186\/s12902-022-00980-1.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"1188_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1080\/07853890.2022.2039956","volume":"54","author":"R Huang","year":"2022","unstructured":"Huang R, Cheng Z, Jin X, et al. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China. Ann Med. 2022;54(1):622\u201332. https:\/\/doi.org\/10.1080\/07853890.2022.2039956.","journal-title":"Ann Med"},{"issue":"23","key":"1188_CR21","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1001\/jama.2018.17365","volume":"320","author":"S Paul","year":"2018","unstructured":"Paul S, Davis AM. Diagnosis and management of nonalcoholic fatty liver disease. JAMA. 2018;320(23):2474\u20135. https:\/\/doi.org\/10.1001\/jama.2018.17365.","journal-title":"JAMA"},{"issue":"9","key":"1188_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","volume":"16","author":"V Nobili","year":"2019","unstructured":"Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol. 2019;16(9):517\u201330. https:\/\/doi.org\/10.1038\/s41575-019-0169-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"1188_CR23","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387\u201395. https:\/\/doi.org\/10.1002\/hep.20466.","journal-title":"Hepatology"},{"issue":"7","key":"1188_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138. https:\/\/doi.org\/10.1016\/j.dld.2009.08.002.","journal-title":"Dig Liver Dis"},{"key":"1188_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biology11050685","author":"K Song","year":"2022","unstructured":"Song K, Lee HW, Choi HS, et al. Comparison of the modified TyG indices and other parameters to predict non-alcoholic fatty liver disease in youth. Biology. 2022. https:\/\/doi.org\/10.3390\/biology11050685.","journal-title":"Biology"},{"key":"1188_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.trsl.2020.08.003","volume":"228","author":"B Park","year":"2021","unstructured":"Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort. Transl Res. 2021;228:42\u201351. https:\/\/doi.org\/10.1016\/j.trsl.2020.08.003.","journal-title":"Transl Res"},{"issue":"12","key":"1188_CR27","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s40618-021-01608-2","volume":"44","author":"M Mirr","year":"2021","unstructured":"Mirr M, Skrypnik D, Bogda\u0144ski P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021;44(12):2831\u201343. https:\/\/doi.org\/10.1007\/s40618-021-01608-2.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1188_CR28","doi-asserted-by":"publisher","first-page":"101345","DOI":"10.1016\/j.diabet.2022.101345","volume":"48","author":"B Rivi\u00e8re","year":"2022","unstructured":"Rivi\u00e8re B, Jaussent A, Macioce V, et al. The triglycerides and glucose (TyG) index: a new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. Diabetes Metab. 2022;48(4):101345. https:\/\/doi.org\/10.1016\/j.diabet.2022.101345.","journal-title":"Diabetes Metab"},{"issue":"7","key":"1188_CR29","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity: comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351. https:\/\/doi.org\/10.1210\/jc.2010-0288.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1188_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280.","journal-title":"Diabetes Metab J"},{"key":"1188_CR31","doi-asserted-by":"publisher","first-page":"597648","DOI":"10.3389\/fendo.2020.597648","volume":"11","author":"C Luci","year":"2020","unstructured":"Luci C, Bourinet M, Lecl\u00e8re PS, Anty R, Gual P. Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies. Front Endocrinol. 2020;11:597648. https:\/\/doi.org\/10.3389\/fendo.2020.597648.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1188_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12933-017-0604-9","volume":"16","author":"BS Karam","year":"2017","unstructured":"Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120. https:\/\/doi.org\/10.1186\/s12933-017-0604-9.","journal-title":"Cardiovasc Diabetol"},{"key":"1188_CR33","doi-asserted-by":"publisher","first-page":"9547613","DOI":"10.1155\/2018\/9547613","volume":"2018","author":"M Masarone","year":"2018","unstructured":"Masarone M, Rosato V, Dallio M, et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2018;2018:9547613. https:\/\/doi.org\/10.1155\/2018\/9547613.","journal-title":"Oxid Med Cell Longev"},{"key":"1188_CR34","doi-asserted-by":"publisher","first-page":"5628749","DOI":"10.1155\/2018\/5628749","volume":"2018","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li P, Miao M, et al. Nonalcoholic fatty liver disease is associated with increased atrial fibrillation risk in an elderly Chinese population: a cross-sectional study. Biomed Res Int. 2018;2018:5628749. https:\/\/doi.org\/10.1155\/2018\/5628749.","journal-title":"Biomed Res Int"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01188-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01188-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01188-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:17:32Z","timestamp":1700489852000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01188-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01188-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"22 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies using human subjects were reviewed and approved by the Medical Research Ethics Committee of the Second Affiliated Hospital of Nanchang University.\u00a0According to national laws and institutional requirements, this study does not require the written informed consent of the subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"\u00a0The author states that there are no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}